BlackRock’s Orchestra BioMed OBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.7M | Buy |
635,714
+4,813
| +0.8% | +$20.5K | ﹤0.01% | 4042 |
|
|
2025
Q4 | $2.62M | Sell |
630,901
-33,432
| -5% | -$135K | ﹤0.01% | 4051 |
|
|
2025
Q3 | $1.65M | Sell |
664,333
-17,016
| -2% | -$46.9K | ﹤0.01% | 4152 |
|
|
2025
Q2 | $1.83M | Sell |
681,349
-1,264,307
| -65% | -$3.69M | ﹤0.01% | 4083 |
|
|
2025
Q1 | $8.33M | Sell |
1,945,656
-33,174
| -2% | -$165K | ﹤0.01% | 3409 |
|
|
2024
Q4 | $7.92M | Buy |
1,978,830
+36,439
| +2% | +$196K | ﹤0.01% | 3542 |
|
|
2024
Q3 | $9.98M | Buy |
1,942,391
+77,418
| +4% | +$506K | ﹤0.01% | 3408 |
|
|
2024
Q2 | $15.2M | Buy |
1,864,973
+423,784
| +29% | +$2.45M | ﹤0.01% | 3145 |
|
|
2024
Q1 | $7.6M | Sell |
1,441,189
-27,579
| -2% | -$187K | ﹤0.01% | 3491 |
|
|
2023
Q4 | $13.4M | Buy |
1,468,768
+138,854
| +10% | +$948K | ﹤0.01% | 3242 |
|
|
2023
Q3 | $11.6M | Buy |
1,329,914
+474,347
| +55% | +$3.19M | ﹤0.01% | 3249 |
|
|
2023
Q2 | $5.99M | Buy |
855,567
+150,892
| +21% | +$2.29M | ﹤0.01% | 3650 |
|
|
2023
Q1 | $13.8M | Sell |
704,675
-85,761
| -11% | -$993K | ﹤0.01% | 3153 |
|
|
2022
Q4 | $7.89M | Hold |
790,436
| – | – | ﹤0.01% | 3503 |
|
|
2022
Q3 | $7.83M | Sell |
790,436
-4,704
| -0.6% | -$46.6K | ﹤0.01% | 3551 |
|
|
2022
Q2 | $7.92M | Hold |
795,140
| – | – | ﹤0.01% | 3619 |
|
|
2022
Q1 | $7.88M | Sell |
795,140
-2,208
| -0.3% | -$21.8K | ﹤0.01% | 3713 |
|
|
2021
Q4 | $8.04M | Hold |
797,348
| – | – | ﹤0.01% | 3790 |
|
|
2021
Q3 | $7.88M | Hold |
797,348
| – | – | ﹤0.01% | 3782 |
|
|
2021
Q2 | $8.13M | Sell |
797,348
-2,652
| -0.3% | -$27.4K | ﹤0.01% | 3716 |
|
|
2021
Q1 | $8.95M | Hold |
800,000
| – | – | ﹤0.01% | 3640 |
|
|
2020
Q4 | $10.2M | Hold |
800,000
| – | – | ﹤0.01% | 3346 |
|
|
2020
Q3 | $8.8M | Buy |
+800,000
| New | +$8.98M | ﹤0.01% | 3296 |
|
Other funds holding OBIO
RI
PA
VCM
PBM
AAA
DMKJ